Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-23
DOI
10.1186/s12964-020-00653-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment
- (2020) Timothy P. Brown et al. ONCOGENE
- TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells
- (2020) Cyril Corbet et al. Nature Communications
- A lactate-induced Snail/STAT3 pathway drives GPR81 expression in lung cancer cells
- (2019) Qiang Xie et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Lactate‐fueled oxidative metabolism drives DNA methyltransferase 1‐mediated transcriptional co‐activator with PDZ binding domain protein activation
- (2019) Tao Huang et al. CANCER SCIENCE
- Upregulation of lactate-inducible snail protein suppresses oncogene-mediated senescence through p16INK4a inactivation
- (2018) Xiangrui Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
- (2018) Maria Apicella et al. Cell Metabolism
- Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells
- (2017) J Feng et al. ONCOGENE
- Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
- (2017) Medhi Wangpaichitr et al. Oncotarget
- Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape
- (2016) K. A. Olaussen et al. ANNALS OF ONCOLOGY
- Metabolic Heterogeneity in Human Lung Tumors
- (2016) Christopher T. Hensley et al. CELL
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation
- (2016) Yi Tang et al. NATURE CELL BIOLOGY
- Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species
- (2016) Monika Papiez et al. Drug Design Development and Therapy
- G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion
- (2016) Yu Jin Lee et al. Oncotarget
- Lactic dehydrogenase and cancer an overview
- (2015) Silvio Naviglio Frontiers in Bioscience-Landmark
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
- (2015) Francesca Zanconato et al. NATURE CELL BIOLOGY
- Nivolumab in NSCLC: latest evidence and clinical potential
- (2015) Raghav Sundar et al. Therapeutic Advances in Medical Oncology
- Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches
- (2015) Meghan Shea et al. Therapeutic Advances in Respiratory Disease
- Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
- (2013) Susan P.C. Cole Annual Review of Pharmacology and Toxicology
- Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
- (2013) Elizabeth J. Sullivan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1α expression in human non-small cell lung cancer cells
- (2012) Lili Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Role of hypoxia-inducible transcription factor 1α for progression and chemosensitivity of murine hepatocellular carcinoma
- (2010) Katjana Daskalow et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
- (2009) R. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
- Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers
- (2008) K. Yonesaka et al. CLINICAL CANCER RESEARCH
- MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer
- (2008) T. Oguri et al. MOLECULAR CANCER THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started